These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy. Lane AM; Kim IK; Gragoudas ES JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates]. Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603 [TBL] [Abstract][Full Text] [Related]
6. Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma. Li W; Gragoudas ES; Egan KM Arch Ophthalmol; 2000 Aug; 118(8):1066-70. PubMed ID: 10922199 [TBL] [Abstract][Full Text] [Related]
7. Salvage proton beam therapy in local recurrent uveal melanoma. Riechardt AI; Cordini D; Dobner B; Seibel I; Gundlach E; Rehak M; Hager A; Stark R; Moser L; Joussen AM Am J Ophthalmol; 2014 Nov; 158(5):948-56. PubMed ID: 25038327 [TBL] [Abstract][Full Text] [Related]
8. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Egger E; Schalenbourg A; Zografos L; Bercher L; Boehringer T; Chamot L; Goitein G Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):138-47. PubMed ID: 11516863 [TBL] [Abstract][Full Text] [Related]
9. Survival after proton-beam irradiation of uveal melanomas. Kodjikian L; Roy P; Rouberol F; Garweg JG; Chauvel P; Manon L; Jean-Louis B; Little RE; Sasco AJ; Grange JD Am J Ophthalmol; 2004 Jun; 137(6):1002-10. PubMed ID: 15183783 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of proton therapy for the treatment of uveal metastases. Kamran SC; Collier JM; Lane AM; Kim I; Niemierko A; Chen YL; MacDonald SM; Munzenrider JE; Gragoudas E; Shih HA Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1044-50. PubMed ID: 25442038 [TBL] [Abstract][Full Text] [Related]
12. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma. Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824 [TBL] [Abstract][Full Text] [Related]
13. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676 [TBL] [Abstract][Full Text] [Related]
14. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221 [TBL] [Abstract][Full Text] [Related]